BRPI0410710A - composições e métodos que compreendem compostos de gastrina e seus usos - Google Patents

composições e métodos que compreendem compostos de gastrina e seus usos

Info

Publication number: BRPI0410710A
Authority: BR; Brazil
Prior art keywords: compositions; methods; gastrin compounds; compounds; beneficial effects
Prior art date: 2003-05-27

Application number

BRPI0410710-1A

Other languages

English (en)

Portuguese (pt)

Inventor

Antonio Cruz

Original Assignee

Waratah Pharmaceuticals Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-05-27

Filing date

2004-05-27

Publication date

2006-06-13

2003-05-27 Priority claimed from PCT/US2003/016660 external-priority patent/WO2003100024A2/en

2004-05-27 Application filed by Waratah Pharmaceuticals Inc filed Critical Waratah Pharmaceuticals Inc

2006-06-13 Publication of BRPI0410710A publication Critical patent/BRPI0410710A/pt

Links

239000000203 mixture Substances 0.000 title abstract 4
AOXOCDRNSPFDPE-UKEONUMOSA-N chembl413654 Chemical class C([C@H](C(=O)NCC(=O)N[C@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@H](CCSC)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC=1C=CC=CC=1)C(N)=O)NC(=O)[C@@H](C)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H]1N(CCC1)C(=O)CNC(=O)[C@@H](N)CCC(O)=O)C1=CC=C(O)C=C1 AOXOCDRNSPFDPE-UKEONUMOSA-N 0.000 title 1
230000009286 beneficial effect Effects 0.000 abstract 2
102100021022 Gastrin Human genes 0.000 abstract 1
108010052343 Gastrins Proteins 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
206010012601 diabetes mellitus Diseases 0.000 abstract 1
-1 gastrin compound Chemical class 0.000 abstract 1
230000002459 sustained effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/2207—Gastrins; Cholecystokinins [CCK]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Diabetes (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Gastroenterology & Hepatology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Endocrinology (AREA)
Animal Behavior & Ethology (AREA)
Obesity (AREA)
Organic Chemistry (AREA)
Zoology (AREA)
Immunology (AREA)
Emergency Medicine (AREA)
Hematology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
General Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

BRPI0410710-1A 2003-05-27 2004-05-27 composições e métodos que compreendem compostos de gastrina e seus usos BRPI0410710A (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
PCT/US2003/016660 WO2003100024A2 (en)	2002-05-24	2003-05-27	Treatment for diabetes
PCT/CA2004/000769 WO2004105780A2 (en)	2003-05-27	2004-05-27	Compositions comprising gastrin compounds and their use in diabetes

Publications (1)

Publication Number	Publication Date
BRPI0410710A true BRPI0410710A (pt)	2006-06-13

Family

ID=33488788

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0410710-1A BRPI0410710A (pt)	2003-05-27	2004-05-27	composições e métodos que compreendem compostos de gastrina e seus usos

Country Status (11)

Country	Link
EP (1)	EP1648495A2 (pl)
JP (1)	JP2007513059A (pl)
CN (1)	CN1829528A (pl)
AU (1)	AU2004243541A1 (pl)
BR (1)	BRPI0410710A (pl)
CA (1)	CA2527186A1 (pl)
MX (1)	MXPA05012605A (pl)
NO (1)	NO20055582L (pl)
PL (1)	PL379145A1 (pl)
RU (1)	RU2005140518A (pl)
WO (1)	WO2004105780A2 (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2315350T3 (es)	2001-01-12	2009-04-01	Waratah Pharmaceuticals Inc.	Composiciones para la introduccion de la neogenesis de islotes, que contienen unos ligandos para el receptor de gastrina/cck y ligandos para el receptor de efg.
EP1837031B1 (en)	2002-06-07	2009-10-14	Waratah Pharmaceuticals, Inc.	Compositions and methods for treating diabetes
CA2486584A1 (en)	2002-06-07	2003-12-18	Waratah Pharmaceuticals, Inc.	Compositions and methods for treating diabetes
BRPI0507189A (pt) *	2004-01-30	2007-06-26	Waratah Pharmaceuticals Inc	uso combinado de um agonista de glp-1 e compostos de gastrina
US20100256061A1 (en) *	2007-03-02	2010-10-07	Antonio Cruz	Gastrin compound for diabetes treatment

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6558952B1 (en) *	1992-12-14	2003-05-06	Waratah Pharmaceuticals, Inc.	Treatment for diabetes
ES2185663T3 (es) *	1994-01-24	2003-05-01	Waratah Pharmaceuticals Inc	Tratamiento de la diabetes.
ES2315350T3 (es) *	2001-01-12	2009-04-01	Waratah Pharmaceuticals Inc.	Composiciones para la introduccion de la neogenesis de islotes, que contienen unos ligandos para el receptor de gastrina/cck y ligandos para el receptor de efg.
MXPA05004202A (es) *	2002-10-22	2005-09-20	Waratah Pharmaceuticals Inc	Tratamiento de la diabetes.

2004
- 2004-05-27 WO PCT/CA2004/000769 patent/WO2004105780A2/en not_active Ceased
- 2004-05-27 JP JP2006529497A patent/JP2007513059A/ja active Pending
- 2004-05-27 CA CA002527186A patent/CA2527186A1/en not_active Abandoned
- 2004-05-27 EP EP04737749A patent/EP1648495A2/en not_active Withdrawn
- 2004-05-27 PL PL379145A patent/PL379145A1/pl not_active Application Discontinuation
- 2004-05-27 BR BRPI0410710-1A patent/BRPI0410710A/pt not_active IP Right Cessation
- 2004-05-27 CN CNA200480022042XA patent/CN1829528A/zh active Pending
- 2004-05-27 MX MXPA05012605A patent/MXPA05012605A/es not_active Application Discontinuation
- 2004-05-27 RU RU2005140518/15A patent/RU2005140518A/ru not_active Application Discontinuation
- 2004-05-27 AU AU2004243541A patent/AU2004243541A1/en not_active Withdrawn
2005
- 2005-11-25 NO NO20055582A patent/NO20055582L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
NO20055582L (no)	2006-02-27
JP2007513059A (ja)	2007-05-24
AU2004243541A1 (en)	2004-12-09
NO20055582D0 (no)	2005-11-25
WO2004105780A3 (en)	2005-01-20
WO2004105780A2 (en)	2004-12-09
CN1829528A (zh)	2006-09-06
CA2527186A1 (en)	2004-12-09
EP1648495A2 (en)	2006-04-26
PL379145A1 (pl)	2006-07-24
MXPA05012605A (es)	2006-02-22
RU2005140518A (ru)	2007-07-10

Similar Documents

Publication	Publication Date	Title
BR0307960A (pt)	2005-02-15	N-aminoacetil-pirrolidina-2-carbonitrilas e seu uso como inibidores de ddp-iv
ECSP045429A (es)	2005-01-03	Combinacion de compuestos organicos
BR0316609A (pt)	2005-10-11	Sinomenina e compostos de sinomenina, sìntese e uso
BR0316350A (pt)	2005-09-27	Diaminotriazóis úteis como inibidores de proteìna cinases
BRPI0412689A (pt)	2006-10-03	derivados de heteroarila e arila fundida como moduladores de metabolismo e a profilaxia e tratamento de distúrbios relacionados a ele
BRPI0411862A (pt)	2006-08-08	combinações de substáncias ativas com propriedades inseticidas e acaricidas
ECSP088152A (es)	2008-02-20	7-aza-indazoles sustituidos, composiciones que los contienen, procedimiento de fabricación y utilización
BR0214343A (pt)	2004-09-14	Inibidores de 11 - beta - hidroxi esteróide desidrogenase tipo 1
CR20150097A (es)	2015-04-14	Composición inmunogénica
BRPI0515316A (pt)	2008-07-15	compostos de imidazoquinolina
EA200201271A1 (ru)	2003-04-24	Ингибиторы 11-бета-гидроксистероиддегидрогеназы типа 1
ECSP10010735A (es)	2011-01-31	Compuestos químicos 251
BR0312232A (pt)	2005-05-10	Inibidores de caspases e seus usos
MX2009000657A (es)	2009-05-28	Composiciones y metodos para el tratamiento de mucositis.
ECSP088252A (es)	2008-04-28	7-aza-indazoles sustituidos, composiciones que los contienen, procedimiento de fabricación y utilización
IS8485A (is)	2006-05-26	Notkun á setnum 2-amínótetralínum í fyrirbyggjandi meðferð á Parkinsons-veiki
ATE516339T1 (de)	2011-07-15	Verwendung von isomeren von bicycloä2.2.1ühept-5- en-2-carbonsäure, ethylester in parfumzusammensetzungen, sowie parfumzusammensetzungen
BRPI0517846A (pt)	2008-10-21	azaindolcarboxamidas
DE602004014937D1 (de)	2008-08-21	Piperidin-verbindungen als malonyl-coa decarboxylase-hemmer
PL1809288T3 (pl)	2012-04-30	Zastosowanie pochodnych 1,4-bis-(3-aminoalkilo)piperazyny do leczenia chorób neurodegeneracyjnych
BRPI0412862A (pt)	2006-10-03	derivados da nicotinamida úteis como inibidores de pde4
BRPI0411087A (pt)	2006-07-25	aperfeiçoamentos em ou relacionados a compostos orgánicos
SE0004101D0 (sv)	2000-11-09	New use
BRPI0412357A (pt)	2006-09-05	combinações de substáncias ativas com propriedades inseticidas e acaricidas
NO20063619L (no)	2006-10-09	Diarylmetylpiperazinderivater, fremstilling og anvendelse derav

Legal Events

Date	Code	Title	Description
2012-05-22	B08F	Application fees: dismissal - article 86 of industrial property law	Free format text: REFERENTE AS 6A, 7A E 8A ANUIDADES.
2012-10-16	B08K	Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)	Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2159 DE 22/05/2012.